Perform comprehensive physical exam, breast imaging, and core needle biopsy confirmation. Ensure patient is NPO for at least 8 hours prior to surgery. Conduct mandatory pre-anesthesia evaluation, blood work (CBC, coagulation profile), and type/crossmatch for blood products. Verify antibiotic prophylaxis administration within 60 minutes of incision.
Monitor vital signs and neurovascular status of the affected limb in the post-anesthesia care unit. Manage pain with multimodal analgesia. Assess surgical site for hematoma or seroma formation and monitor drain output daily. Implement early mobilization and physical therapy exercises to prevent shoulder stiffness. Discharge occurs once drain output is minimal and patient is hemodynamically stable.
Comprehensive Guide to Axillary Lymph Node Dissection (ALND)
Axillary Lymph Node Dissection (ALND) remains a cornerstone surgical procedure in the management of breast cancer and certain malignant melanomas. While the surgical landscape has shifted toward less invasive techniques like Sentinel Lymph Node Biopsy (SLNB), ALND continues to play a critical role in staging, local control, and therapeutic intervention for patients with clinically node-positive disease.
1. Introduction and Overview
ALND is a surgical procedure involving the removal of lymph nodes from the axilla (the armpit). In the context of oncology, it is primarily performed to remove cancerous lymph nodes that have spread from a primary tumor site, most commonly the breast.
Historically, ALND was the standard of care for all breast cancer patients. However, the paradigm has shifted significantly with the advent of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial and the NSABP B-04 trial, which redefined the necessity of extensive nodal clearance in specific patient populations. Today, ALND is a nuanced surgical decision balancing the need for oncological clearance against the morbidity of lymphedema and nerve injury.
2. Technical Specifications and Mechanism
The axilla is organized into three levels based on the relationship of the lymph nodes to the pectoralis minor muscle (Berg’s levels):
| Level | Anatomical Landmark |
|---|---|
| Level I | Lateral to the lateral border of the pectoralis minor muscle. |
| Level II | Posterior to the pectoralis minor muscle. |
| Level III | Medial to the medial border of the pectoralis minor muscle (apical nodes). |
The Surgical Mechanism
The procedure aims to remove fat-pad tissue containing lymph nodes from Levels I and II. Level III dissection is rarely performed today unless there is gross involvement, as it significantly increases the risk of morbidity without providing a clear survival benefit.
Key Surgical Landmarks for the Surgeon:
* Long Thoracic Nerve: Runs along the lateral chest wall (serratus anterior muscle). Injury leads to "winged scapula."
* Thoracodorsal Nerve: Innervates the latissimus dorsi muscle.
* Medial Pectoral Nerve: Often sacrificed to clear Level II nodes effectively.
* Intercostobrachial Nerve: A sensory nerve often transected, leading to numbness in the medial upper arm.
3. Clinical Indications and Usage
ALND is indicated when there is proven metastatic disease in the axilla.
Primary Indications:
- Clinically Positive Nodes: Patients with palpable axillary lymphadenopathy or biopsy-proven nodal metastasis.
- Failed Sentinel Lymph Node Biopsy: If the sentinel node is positive in a patient who does not meet Z0011 criteria (e.g., mastectomy patients or those with high-burden macrometastases).
- Extracapsular Extension: Presence of tumor cells extending beyond the lymph node capsule.
- Recurrent Disease: Persistent or recurrent axillary disease after previous breast-conserving therapy.
Contraindications:
- Distant Metastasis (Stage IV): ALND is generally not indicated for systemic control in Stage IV disease, except for palliative purposes (e.g., ulcerating axillary masses).
- Poor Performance Status: Patients unable to tolerate general anesthesia or those with limited life expectancy.
4. Pre-Operative Preparation
Preparation is critical to minimize intraoperative risks and optimize post-operative recovery.
- Imaging: Pre-operative breast and axillary ultrasound with fine-needle aspiration (FNA) or core biopsy of suspicious nodes.
- Patient Education: Detailed counseling regarding the high risk of lymphedema (estimated 15–30%).
- Baseline Measurements: Measuring the circumference of the upper and lower arms to monitor for post-operative lymphedema.
- Anesthesia: General anesthesia is standard. Prophylactic antibiotics are administered within 60 minutes of the first incision.
5. The Procedure: Step-by-Step
- Incision: A transverse incision is made in the axillary crease, following the skin lines for optimal cosmetic outcomes.
- Exposure: The clavipectoral fascia is divided, and the pectoralis minor muscle is identified.
- Dissection: The axillary vein is identified as the superior boundary. All nodal tissue inferior to this vein and lateral to the pectoralis minor is removed.
- Preservation: The long thoracic and thoracodorsal nerves are meticulously identified and preserved.
- Hemostasis: Careful electrocautery is used to minimize bleeding.
- Drainage: A closed-suction drain (e.g., Jackson-Pratt) is placed to prevent seroma formation.
- Closure: The skin is closed in layers to reduce tension.
6. Post-Operative Recovery Protocol
Recovery focuses on wound healing, pain management, and early physical therapy.
- Drain Management: Drains are typically removed when output falls below 30cc per 24 hours (usually 7–14 days).
- Physical Therapy: Gentle range-of-motion (ROM) exercises should begin on the first or second post-operative day to prevent "frozen shoulder."
- Activity Restrictions: No lifting objects over 5–10 lbs for 4–6 weeks.
- Lymphedema Prevention: Avoid blood pressure cuffs, venipuncture, and injections in the affected arm for life.
7. Risks and Potential Complications
ALND is associated with significant morbidity compared to SLNB.
| Complication | Mechanism | Management |
|---|---|---|
| Seroma | Fluid collection in the dead space | Aspiration or drain re-insertion |
| Lymphedema | Disruption of lymphatic drainage | Compression garments, MLD therapy |
| Nerve Injury | Mechanical traction or transection | Physical therapy, neuro-monitoring |
| Infection | Surgical site contamination | Antibiotics, wound debridement |
| Shoulder Stiffness | Pain-related guarding | Early PT intervention |
8. Alternative Treatments
The medical community has moved toward de-escalation:
* Sentinel Lymph Node Biopsy (SLNB): Removing only the first 1–3 nodes. If negative, the patient avoids ALND.
* Axillary Radiation: Recent trials (AMAROS) suggest that axillary radiation can achieve similar local control to ALND in node-positive patients with lower rates of lymphedema.
* Neoadjuvant Chemotherapy (NAC): Downstaging axillary disease prior to surgery can sometimes allow for SLNB instead of full ALND.
9. Frequently Asked Questions (FAQ)
1. Will I definitely get lymphedema after ALND?
Not necessarily. While the risk is high (up to 30%), it is not guaranteed. Early physical therapy and avoiding trauma to the arm significantly lower the risk.
2. Can I have blood drawn from my arm after surgery?
It is highly recommended to avoid blood pressure measurements, IV lines, and blood draws in the affected arm for the rest of your life to minimize the risk of lymphedema.
3. How long does the drain stay in?
Usually between 7 and 14 days. The drain is removed once the daily output is low enough to prevent fluid buildup (seroma).
4. What is the difference between SLNB and ALND?
SLNB removes only the primary nodes that drain the tumor. ALND is a comprehensive removal of multiple levels of lymph nodes.
5. Will I lose sensation in my arm?
Many patients experience numbness on the inner aspect of the upper arm due to the sacrifice of the intercostal-brachial nerve. This is usually permanent but typically manageable.
6. Can I exercise after the surgery?
Yes, but you must start slowly. Follow your surgeon’s specific "range of motion" protocol. Avoid heavy lifting until cleared by your surgical team.
7. Does ALND affect my survival rate?
ALND provides excellent local control of disease. However, systemic survival is primarily dictated by the biology of the tumor and adjuvant therapies (chemotherapy, endocrine therapy).
8. What is a seroma?
A seroma is a collection of lymphatic fluid in the surgical site. It is the most common complication of ALND and usually resolves with simple drainage.
9. Why is the Long Thoracic Nerve so important?
If this nerve is damaged, the serratus anterior muscle becomes paralyzed, causing the scapula (shoulder blade) to protrude from the back, known as "winged scapula."
10. Can I wear a compression sleeve?
If you develop signs of lymphedema, a certified lymphedema therapist will likely prescribe a custom compression garment to help manage swelling.
10. Conclusion
Axillary Lymph Node Dissection remains a vital tool for oncologic surgeons. While the field has evolved to prioritize less invasive methods, the surgical clearance of the axilla is still an essential procedure for patients with significant nodal burden. The key to successful outcomes lies in meticulous surgical technique, early physical rehabilitation, and lifelong awareness of lymphedema prevention strategies. Patients should engage in shared decision-making with their oncological team to determine if ALND is the most appropriate step in their specific cancer treatment journey.
Disclaimer: This guide is for educational purposes only and does not constitute medical advice. Always consult with your surgical oncologist or healthcare provider regarding your specific medical condition and treatment plan.
